Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary
- PMID: 2553044
- DOI: 10.1016/0893-133x(89)90007-9
Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary
Abstract
We examined the effects of chronic treatment with antidepressants (imipramine or desipramine) or benzodiazepines (diazepam, alprazolam, or adinazolam) on modulation of corticotropin-releasing-factor (CRF) receptors in discrete areas of rat brain and in anterior pituitary. As previously reported, we found that chronic antidepressant treatment downregulated 5-HT2 serotonin and beta-adrenergic receptors in cerebral cortex. Although there was a trend toward increased CRF binding in brain stem, striatum, cerebellum, hypothalamus, and frontal cerebral cortex following antidepressant treatment, the changes were only statistically significant in brain stem in imipramine-treated rats. In addition, no significant changes were seen in CRF binding in other brain regions including parietal/temporal cerebral cortex, olfactory bulb, hippocampus, and anterior pituitary. Following chronic benzodiazepine treatment CRF receptor binding was significantly decreased in the frontal cerebral cortex and hippocampus; although there was a trend for CRF receptors to be decreased in other brain areas and increased in anterior pituitary, the changes were not statistically significant.
Similar articles
-
Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.Synapse. 1989;4(3):196-202. doi: 10.1002/syn.890040304. Synapse. 1989. PMID: 2575286
-
Age-related decreases in corticotropin-releasing factor (CRF) receptors in rat brain and anterior pituitary gland.Brain Res. 1991 Feb 22;542(1):155-8. doi: 10.1016/0006-8993(91)91011-o. Brain Res. 1991. PMID: 1647252
-
Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats.Eur J Pharmacol. 1992 Apr 22;214(2-3):233-8. doi: 10.1016/0014-2999(92)90123-l. Eur J Pharmacol. 1992. PMID: 1355436
-
[Antidepressant drugs and central monoaminergic receptors].Yakubutsu Seishin Kodo. 1985 Dec;5(4):303-19. Yakubutsu Seishin Kodo. 1985. PMID: 2870595 Review. Japanese.
-
Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.Neuroendocrinology. 1986;43(1):79-88. doi: 10.1159/000124513. Neuroendocrinology. 1986. PMID: 3012395 Review.
Cited by
-
Innovative approaches for the treatment of depression: targeting the HPA axis.Neurochem Res. 2008 Apr;33(4):691-707. doi: 10.1007/s11064-007-9518-3. Epub 2007 Oct 25. Neurochem Res. 2008. PMID: 17960478 Review.
-
Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain.J Psychiatry Neurosci. 1995 Jan;20(1):25-32. J Psychiatry Neurosci. 1995. PMID: 7865498 Free PMC article.
-
Differences in Leukocyte Telomere Length between Coronary Heart Disease and Normal Population: A Multipopulation Meta-Analysis.Biomed Res Int. 2019 May 6;2019:5046867. doi: 10.1155/2019/5046867. eCollection 2019. Biomed Res Int. 2019. PMID: 31198785 Free PMC article.
-
Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.Psychopharmacology (Berl). 2016 Mar;233(6):1077-86. doi: 10.1007/s00213-015-4187-4. Epub 2015 Dec 23. Psychopharmacology (Berl). 2016. PMID: 26700241
-
Benzodiazepines and anterior pituitary function.J Endocrinol Invest. 2002 Sep;25(8):735-47. doi: 10.1007/BF03345110. J Endocrinol Invest. 2002. PMID: 12240908 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials